Coherus Biosciences Inc
CHRS
Market Cap$127.49M
Close$
$7.71
677% upside
Current Fair Value
677% upsideUndervalued by 677% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $127.49 Million |
|---|---|
| Enterprise Value | $1.50 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $0.25 |
| Beta | 1.01 |
| Outstanding Shares | 115,418,069 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 4.45 |
|---|---|
| PEG | -12.25 |
| Price to Sales | 0.5 |
| Price to Book Ratio | 0.33 |
| Enterprise Value to Revenue | 0.01 |
| Enterprise Value to EBIT | -0.01 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Coherus Biosciences Inc
CEO: Dennis Lanfear